Drugs / Timothy, Phleum pretense
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01924208 Comparator | Oct 2013 → Sep 2016 | — | Turku University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Timothy, Phleum pretense | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01924208 ↗ |
| Known as | Grazax | “Allergen. Grazax® sublingual 75.000 SQ-T tablet (extracted from timothy, Phleum pretense), once daily until operation (ALK-Abelló, Hørsholm, Denmark) (n=30) .” NCT01924208 ↗ |